Rift Valley fever MP-12 vaccine Phase 2 clinical trial: Safety, immunogenicity, and genetic characterization of virus isolates
Titel:
Rift Valley fever MP-12 vaccine Phase 2 clinical trial: Safety, immunogenicity, and genetic characterization of virus isolates
Auteur:
Pittman, Phillip R. Norris, Sarah L. Brown, Elizabeth S. Ranadive, Manmohan V. Schibly, Barbara A. Bettinger, George E. Lokugamage, Nandadeva Korman, Lawrence Morrill, John C. Peters, Clarence J.